20251 ⎘
Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
NOVEL INHIBITORS OF BACTERIAL BIOFILMS AND RELATED METHODS
#602Methods of treating autism
#603Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia
#604NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS
#605Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria
#606ROS-activated compounds as selective anti-cancer therapeutics
#607Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
#608Therapeutic compositions
#609Therapeutic compositions
#610Topical compositions comprising fipronil and permethrin and methods of use
#611Liposomal formulation for ocular drug delivery
#612Methods for inhibiting muscle atrophy
#613Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
#614METHOD OF DRUG DETOXIFICATION
#615Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
#616Anti-viral carbamimidothioic acid esters
#617Composition and uses for influencing hair growth
#618Compound Used to Prevent Diseases Caused by Aquaporin Deficiency
#619Treatment for meibomian gland dysfunction or obstruction
#620TREATING CANCER WITH STATINS AND COMPOUNDS HAVING DIPYRIDAMOLE ACTIVITY
#621COMPOSITION AND METHOD FOR TREATMENT OF INSECT BITES
#622Agent for treating Parkinson's disease
#623ANTIMICROBIAL COMPOSITION
#624Derivative of 18β-glycyrrhetinic acid apt to suppress cancer cells
#625Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
#626Cyclohexylamines
#627INDUCING INACTIVATION OF FIBROGENIC MYOFIBROBLASTS
#628Compositions of jasmonate compounds
#629Formulations and uses of retinoic acid receptor selective agonists
#630Retinal derivatives and methods for the use thereof for the treatment of visual disorders
#631Process for the preparation of pleuromutilins
#63218β-Glycyrrhetinic acid derivatives and synthetic method thereof
#633Methods for the treatment and prevention of age-related retinal dysfunction
#634Retinal derivatives and methods for the use thereof for the treatment of visual disorders
#635Retinal derivatives and methods for the use thereof for the treatment of visual disorders
#636Methods for the treatment and prevention of age-related retinal dysfunction
#637Retinal derivatives and methods for the use thereof for the treatment of visual disorders
#638Methods for treating obesity or an obesity related condition
#639ANXIOYTIC MARCGRAVIACEAE COMPOSITIONS CONTAINING BETULINIC ACID, BETULINIC ACID DERIVATIVES, AND METHODS
#640Anti-viral formulations
#641Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#642NUTRITIONAL SUPPLEMENT FOR USE UNDER PHYSIOLOGICALLY STRESSFUL CONDITIONS
#643ANTIMICROBIAL COMPOSITION
#644Boswellia oil, its fractions and compositions for enhancing brain function
#645Method for inhibition of potential-dependent cation channel
#646PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES
#647Treatment of osteoporosis
#648Materials and Methods for Prevention and Treatment of Viral Infections
#649Methods and compounds for reducing intracellular lipid storage
#650Compounds and compositions for treating infection
#651Methods of Treating Autism
#652Methods of Treating Fragile X Syndrome
#653Pharmaceutical or veterinary antiviral compositions
#654Esters for treatment of ocular inflammatory conditions
#655Novel Uses of Neuraminidase Inhibitors in Infectious Diseases
#656Esters for treatment of ocular inflammatory conditions
#657Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#658Metabolic imprinting effects of structured lipids
#659Omega-3 fatty acid nutriceutical composition and optimization method
#660Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
#661PHARMACEUTICAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF
#662Compositions and Methods for the Therapy and Diagnosis of Influenza
#663Therapeutic compositions
#664Water-swellable polymers
#665Method of enhancing hair growth
#666Boswellia low polar gum resin extract and its synergistic compositions
#667Therapeutic compositions
#668Therapeutic compositions
#669METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION
#670USE OF JASMONE FOR MODULATING MELATONIN PRODUCTION AND CALCIFICATION OF THE PINEAL GLAND
#671LIQUID STATIN FORMULATION
#672Compositions and methods for treating cardiovascular diseases
#673Compositions and methods for treating chronic inflammation and inflammatory diseases
#674Compositions and soft tissue replacement methods
#675Ocular system with anchoring implant and therapeutic agent
#676CATECHINS FOR THE TREATMENT OF AMYLOIDOSIS
#677Pharmaceutical compositions having desirable bioavailability
#678COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH
#679MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION
#680Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
#681Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger
#682Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism
#683EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
#684COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS
#685N-alkylcarbonyl-amino acid ester compounds and their use for cough and pharyngitis
#686Methods and Compositions for the Treatment of Gastrointestinal Disorders
#687Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate
#688Compositions and methods relating to proliferative diseases
#689Methods of treating autism
#690COMPOUND USED TO PREVENT DISEASES CAUSED BY AQUAPORIN DEFICIENCY
#691Calcium sensing receptor modulating compounds and pharmaceutical use thereof
#692TREATMENT OF EYE DISCOMFORT BY TOPICAL ADMINISTRATION OF A COOLING AGENT TO THE EXTERNAL SURFACE OF THE EYELID
#693Methods of treating fragile X syndrome
#694Use of huperzine for disorders
#695METHOD OF TREATING CONDITIONS ASSOCIATED WITH OVERACTIVE BLADDER
#696USE OF JASMONATE ESTER DERIVATIVES FOR TREATING BENIGN HYPERPROLIFERATIVE SKIN DISORDERS
#697Method for producing bicyclic γ-amino acid derivative
#698Topical parasiticide composition
#699Metallo-β-lactamase inhibitors
#700STABLE PROSTAGLANDIN-CONTAINING COMPOSITIONS
#701PRODRUG COMPRISING BETA-KETO CARBOXYLIC ACID, BETA-KETO CARBOXYLIC ACID SALT OR BETA-KETO CARBOXYLIC ACID ESTER FOR DRUG DELIVERY
#702Antiviral treatments
#703()-(-)-1,2-propanediol compositions and methods
#704Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
#705EPIGENETIC MECHANISMS RE-ESTABLISH ACCESS TO LONG-TERM MEMORY AFTER NEURONAL LOSS
#706Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
#707PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS
#708Pharmaceutical compositions having desirable bioavailability
#709Pleuromutilin derivatives for the treatment of diseases mediated by microbes
#710Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
#711MEDICAL DIETARY COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES
#712TRIHEPTANOIN DIET FOR ADULT POLYGLUCOSAN BODY DISEASE (APBD) TREATMENT
#713PHARMACEUTICAL FORMULATION BETWEEN JASMONATES AND IT DERIVATIVES AND NANOCARRIES OR MICROCARRIES
#714METHODS AND COMPOSITIONS FOR TREATING OPTHALMIC CONDITIONS WITH RETINOL DERIVATIVES
#715Retinal derivatives and methods for the use thereof for the treatment of visual disorders
#716COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION
#717MATRIX METALLOPROTEINASE INHIBITOR
#718NEURAMINIDASE INHIBITORS AND USES THEREOF
#719Nasolacrimal drainage system implants for drug therapy
#720Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same
#721PREVENTION AND TREATMENT OF INFLAMMATION-INDUCED AND/OR IMMUNE-MEDIATED BONE LOSS
#722Female Sex Pheromone of the Dogwood Borer (DWB), Synanthedon scitula, and Attraction Inhibitor (Antagonist)
#723Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency
#724COMBINATION THERAPIES FOR TREATMENT OF HYPERTENSION AND COMPLICATIONS IN PATIENTS WITH DIABETES OR METABOLIC SYNDROME
#725METHODS OF IMPROVING QUALITY OF SLEEP
#726Composition for the prevention and treatment of absence seizures comprising PKC agonist as an effective ingredient
#727Method of Treating Asthma with Antiviral Agents
#728Pharmaceutically acceptable salts of betulinic acid derivatives
#729Esters of capsaicin for treating pain
#730EXTRACTS WITH LIVER-X-RECEPTOR MODULATORS, COMPOUNDS AND THEIR USE ESPECIALLY IN WEIGHT CONTROL
#731Formulations for enhanced bioavailability of orally administered polar agents
#732COMPOSITIONS AND METHODS FOR REDUCING THE MUTATION RATE OF VIRUSES
#733Compositions, Methods, and Kits for Treating Influenza Viral Infections
#734Compositions and methods for treating varicose veins
#735Ursolic acid derivative and pharmaceutical composition thereof
#736Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#737Severe sepsis preventive therapeutic agent
#738Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease
#739Topical vaginal preparation
#740Compositions and Methods for Preventing Migraines
#741Treatment for meibomian gland dysfunction or obstruction
#742Composition and uses for influencing hair growth
#743Aminocarboxylic acid derivative and medicinal use thereof
#744Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
#745CATHECHINS FOR THE TREATMENT OF SYSTEMIC AA AMYLOIDOSIS
#746Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#747Water-swellable polymers
#748PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-3 FATTY ACID AND HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME
#749Latanoprost-containing aqueous pharmaceutical composition
#750Skin Circulation-Improving Agent And Skin Temperature-Elevating Agent
#751THERAPEUTIC INTERVENTION TO MIMIC THE EFFECT OF CALORIC RESTRICTION
#752COMPOSITION AND METHODS USED DURING ANTI-HIV TREATMENT
#75318β-glycyrrhetinic acid derivatives and synthetic method thereof
#754Acute Pharmacologic Augmentation of Psychotherapy with Enhancers of Learning or Conditioning
#755Compositions and methods for treating macular degeneration
#756Compositions, Methods, and Kits for Treating Influenza Viral Infections
#757Use of electrophilic compounds for inducing platelet production or maintaining platelet function
#758Pharmaceutical composition for treatment of diabetic complications
#759Methods and compositions for protecting and treating neuroinjury
#760Vector delivery-based microbicides
#761Compounds and methods for treating influenza
#762Non-aqueous oil delivery system for ophthalmic drugs
#763Nitric oxide amino acid ester compound, composition for increasing nitric oxide levels and method of use
#764Methods and compositions for treating ophthalmic conditions with retinyl derivatives
#765Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease
#766P-MENTHAWE-3-CARBOXYLIC ACID ESTERS TO TREAT AIRWAYS DISEASES
#767Use of EDTA and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases
#768Solid formulations of prostacyclin analogs
#769Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
#7702,2-dimethylbutyric acid oral pharmaceutical compositions
#771COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AGING-ASSOCIATED DISEASES
#772Alleviating neuropathic pain with EETs and sEH inhibitors
#773Anthracenedione compounds
#774Use of huperzine for disorders
#775METHOD OF DELIVERING NUTRIENTS
#776Pharmaceutical composition comprising oseltamivir phosphate
#777ANTIDIARRHETIC COMPOSITION, PRODUCT CONTAINING THE SAME AND METHOD OF PREVENTING DIAHHREA
#778PROANTHOCYANIDINS FOR THE TREATMENT OF AMYLOID AND ALPHA-SYNUCLEIN DISEASES
#779OCULOSELECTIVE DRUGS AND PRODRUGS
#780Treatment of neurodegenerative and cardiovascular disorders
#781ESTER COMPOUND AND MEDICAL USE THEREOF
#782Compositions and Methods for Preserving Brain Function
#783Pharmaceutical compositions comprising fesoterodine
#784COMPOSITION FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME CONTAINING OBOVATOL AND ITS SYNTHESIZED DERIVATIVES
#785EYE DROP PREPARATION COMPRISING LATANOPROST
#786HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells
#787Synthesis of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles
#788Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents
#789USE OF COOLING AGENTS TO RELIEVE MILD OCULAR IRRITATION AND ENHANCE COMFORT
#790Local topical administration formulations containing indoxacarb
#791Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
#792Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes
#793Rupestonic acid derivatives and use thereof
#794Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
#795Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
#796COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#797Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
#798Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof
#799COSMETIC PRODUCT FOR THE TREATMENT OF CICATRICIAL TISSUES
#800Agonists of a bitter taste receptor and uses thereof
#801Topical formulations of tellurium-containing compounds
#802Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
#803Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#804Pleuromutilin derivatives for the treatment of diseases mediated by microbes
#805Methods for the treatment and prevention of age-related retinal dysfunction
#806COMPOSITION AND METHOD FOR TREATMENT OF INSECT BITES
#807Methods of treating fragile X syndrome and autism
#808Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside
#809High penetration prodrug compositions of retinoids and retinoid-related compounds
#810Proanthocyanidins for the Treatment of Amyloid and Alpha-Synuclein Diseases
#811Medicinal Agent For Treating Viral Infections
#812In vivo methods of identifying compounds which target suppressed cancer cells
#813CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#814METHOD FOR ENERGIZING HUMAN BEINGS
#815Therapeutic compositions
#816Aminocarboxylic acid derivative and medicinal use thereof
#817SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
#818Pharmaceutical compositions having desirable bioavailability
#819PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY
#820Methods and Compositions for the Treatment of Gastrointestinal Disorders
#821AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES
#822Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists
#823Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#824Substituted Fullerene Formulations and Their Use in Ameliorating Oxidative Stress Diseases or Inhibiting Cell Death
#825GIP SECRETION INHIBITOR
#826Oseltamivir phosphate granule and preparation method thereof
#827Use of Fenofibrate or a Derivative Thereof for Preventing Diabetic Retinopathy
#828EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
#829Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
#830ORGANIC COMPOUNDS
#831Pharmaceutical compositions comprising fesoterodine
#832Compositions and Methods for Preventing Migraines
#833Pharmaceutical Agent
#834Creatine ascorbyl derivatives and methods of use thereof
#835Method of treating atrophic vaginitis
#836Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System
#837Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome
#838USE OF COMPOSITIONS TO ENHANCE INNATE IMMUNE RESPONSE
#839Treatment of Viral Disease and Cancer With Nf-kappaB Inhibitors
#840Compositions and methods for treating inflammation and inflammation-related disorders by extracts
#841Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation
#842USES OF BROAD SPECTRUM RNAI THERAPEUTICS AGAINST INFLUENZA
#843Drug eluting ocular implant with anchor and methods thereof
#844Utilities of olefin derivatives
#845Fenofibrate compositions
#846Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor
#847Ginger Extract For Inhibiting Human Drug Transporters
#848Methods of treating ear infections
#849TOPICAL COMPOSITION FOR TREATING PAIN
#850TOPICAL COMPOSITION FOR TREATING PAIN
#851TOPICIAL COMPOSITION FOR TREATING PAIN
#852Topical composition for treating pain
#853Therapeutic intervention to MIMIC the effect of caloric restriction
#854Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders
#855Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease
#856Combination Therapy with Fumaric Acid Esters for the Treatment of Autoimmune and/or Inflammatory Disorders
#857Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
#858Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
#859CONCENTRATE ESMOLOL
#860Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog
#861Composition Based on Triethyl Citrate for the Prevention of Enzymatic Hydrolysis of Triglycerides
#862Combination Composition
#863Bioeffective krill oil compositions
#864Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#865Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract
#866Medicine For Prevention or Treatment of Frequent Urination or Urinary Incontinence
#867Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
#868Nutritional supplement for women
#869Retinal derivatives and methods for the use thereof for the treatment of visual disorders
#870Composition and methods for treating Alzheimer's disease and other amyloidoses
#871Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
#872PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND PARACETAMOL AND METHODS OF USING THE SAME
#873Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators
#874Method of treatment of virus infections using shikonin compounds
#875USE OF SPECIFIC MENTHYL 3-OXOCARBOXYLIC ACID ESTERS AS PHYSIOLOGICALLY ACTIVE COOLING SUBSTANCES
#876Medicament For Irritable Bowel Syndrome
#877Novel Method
#878Pharmaceutical Composition
#87911Beta -Hydroxysteroid Dehydrogenases
#880Multi-purpose hand and/or skin cleaner, sanitizer, drug delivery and exercise system
#881Pharmaceutical compositions comprising fesoterodine
#882Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators
#883Metallo-β-lactamase inhibitors
#884ANTIVIRAL COMPOSITIONS AND METHODS OF USE
#885METHOD OF INHIBITING THE FORMATION OF ADHESIONS AND SCAR TISSUE AND REDUCING BLOOD LOSS
#886Process for preparing fenofibrate compositions
#887Anti-Hair Graying Agent
#888Modulation of Inflammation Related to Columnar Epithelia
#889Methods for prophylactic and therapeutic nutritional supplementation
#890Fenofibrate compositions
#891Derivatives of sandalwood oil and santalols for treating cold sores and herpes
#892USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR PRODUCING DRUGS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME
#893USE OF PHENYLETHANOLAMINOTETRALINES FOR PREPARING ANXIOLYTIC DRUGS
#894Compositions and methods for the treatment of cystic fibrosis
#895Pharmaceutical compositions comprising amifostine and related compounds
#896Method of treating atrophic vaginitis
#897Process for Effecting the Relaxation of Muscles of a Human by Means of Fragrance
#898Esters of capsaicin for treating pain
#899USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA
#900Drug delivery methods, structures, and compositions for nasolacrimal system